Segall Bryant & Hamill LLC lessened its holdings in Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) by 18.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 265,754 shares of the software maker’s stock after selling 61,909 shares during the quarter. Segall Bryant & Hamill LLC owned approximately 0.15% of Allscripts Healthcare Solutions worth $3,867,000 at the end of the most recent quarter.
A number of other large investors have also bought and sold shares of MDRX. Redmile Group LLC purchased a new position in Allscripts Healthcare Solutions in the fourth quarter valued at $25,762,000. Janney Capital Management LLC grew its holdings in shares of Allscripts Healthcare Solutions by 239.8% during the third quarter. Janney Capital Management LLC now owns 997,009 shares of the software maker’s stock worth $14,187,000 after purchasing an additional 703,598 shares during the last quarter. Community Trust & Investment Co. purchased a new position in shares of Allscripts Healthcare Solutions during the fourth quarter worth about $8,693,000. Amundi Pioneer Asset Management Inc. purchased a new position in shares of Allscripts Healthcare Solutions during the fourth quarter worth about $8,160,000. Finally, Dalton Greiner Hartman Maher & Co. grew its holdings in shares of Allscripts Healthcare Solutions by 18.4% during the fourth quarter. Dalton Greiner Hartman Maher & Co. now owns 2,990,902 shares of the software maker’s stock worth $43,518,000 after purchasing an additional 465,037 shares during the last quarter.
In related news, EVP Brian Farley sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $13.73, for a total value of $68,650.00. Following the completion of the sale, the executive vice president now owns 240,672 shares in the company, valued at $3,304,426.56. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, President Richard J. Poulton sold 15,000 shares of the firm’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $13.53, for a total transaction of $202,950.00. Following the completion of the sale, the president now owns 505,920 shares of the company’s stock, valued at approximately $6,845,097.60. The disclosure for this sale can be found here. 0.75% of the stock is owned by company insiders.
Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings data on Thursday, February 15th. The software maker reported $0.18 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.18. The firm had revenue of $547.00 million during the quarter, compared to the consensus estimate of $524.05 million. Allscripts Healthcare Solutions had a negative net margin of 10.88% and a positive return on equity of 7.36%. The firm’s revenue was up 27.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.14 earnings per share. equities analysts forecast that Allscripts Healthcare Solutions Inc will post 0.56 EPS for the current year.
Several brokerages have issued reports on MDRX. SunTrust Banks lowered Allscripts Healthcare Solutions from a “buy” rating to a “hold” rating in a report on Tuesday, January 16th. They noted that the move was a valuation call. Zacks Investment Research lowered Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a report on Friday, January 12th. Maxim Group reaffirmed a “buy” rating and set a $20.00 price objective on shares of Allscripts Healthcare Solutions in a report on Tuesday, January 9th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $17.00 price objective on shares of Allscripts Healthcare Solutions in a report on Monday, January 8th. Finally, Evercore ISI began coverage on Allscripts Healthcare Solutions in a report on Thursday, January 18th. They set an “outperform” rating and a $17.50 price objective on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. Allscripts Healthcare Solutions currently has an average rating of “Buy” and an average target price of $16.09.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.